uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The sensitivity and specificity of uPAR PET/CT with the radioligand 68GaNOTA-AE105 and FDG
PET/MRI for preoperative detection of regional lymph node metastases in urinary bladder
cancer